SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001725160-20-000034
Filing Date
2020-11-09
Accepted
2020-11-09 07:07:05
Documents
76
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zntl-20200930.htm   iXBRL 10-Q 2019663
2 EX-10.6 employmentagreementgal.htm EX-10.6 159429
3 EX-10.7 employmentagreementpin.htm EX-10.7 158676
4 EX-31.1 zentalis10-qq32020ex311.htm EX-31.1 10074
5 EX-31.2 zentalis10-qq32020ex312.htm EX-31.2 10316
6 EX-32.1 zentalis10-qq32020ex321.htm EX-32.1 5227
7 EX-32.2 zentalis10-qq32020ex322.htm EX-32.2 5622
  Complete submission text file 0001725160-20-000034.txt   7939700

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20200930.xsd EX-101.SCH 43722
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zntl-20200930_cal.xml EX-101.CAL 79430
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20200930_def.xml EX-101.DEF 299378
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20200930_lab.xml EX-101.LAB 523884
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20200930_pre.xml EX-101.PRE 402167
13 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20200930_htm.xml XML 1156852
Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39263 | Film No.: 201296058
SIC: 2834 Pharmaceutical Preparations